Back
Norsk Hydro ASA Vs. Monopar Therapeutics Industry Stock Comparison
Sell
31
NHYDY
Norsk Hydro ASA
Last Price:
5.68
Seasonality Move:
8.69%
Buy
75
MNPR
Monopar Therapeutics
Last Price:
31.00
Seasonality Move:
35.55%
Sell
31
Norsk Hydro ASA (NHYDY)
is a Sell
Is Norsk Hydro ASA a Buy, Sell or Hold?
- The current Norsk Hydro ASA [NHYDY] share price is $5.68. The Score for NHYDY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NHYDY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NHYDY Stock Price Chart
What is Norsk Hydro ASA's stock price today?
-
The Norsk Hydro ASA share price today is $5.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NHYDY is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NHYDY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 33.58 | Sell |
Chaikin Money Flow: | -80704 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.86 - 6.38) | Sell |
Bollinger Bands (100): | (5.45 - 6.33) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.92 | Buy |
Relative Strength Index (14 RSI): | 76.63 | Buy |
Chaikin Money Flow: | 62338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.5 - 24.7) | Buy |
Bollinger Bands (100): | (1.59 - 18.41) | Buy |
NHYDY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.88 | Sell |
20-day SMA: | 6.15 | Sell |
50-day SMA: | 6.19 | Sell |
200-day SMA: | 6.01 | Sell |
8-day EMA: | 5.87 | Sell |
20-day EMA: | 6.03 | Sell |
50-day EMA: | 6.09 | Sell |
200-day EMA: | 6.03 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.74 | Buy |
20-day SMA: | 22.43 | Buy |
50-day SMA: | 16.57 | Buy |
200-day SMA: | 6.79 | Buy |
8-day EMA: | 25.62 | Buy |
20-day EMA: | 22.75 | Buy |
50-day EMA: | 17.67 | Buy |
200-day EMA: | 9.07 | Buy |
Norsk Hydro ASA Earnings Growth & NHYDY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.20 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
Norsk Hydro ASA Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |